The Great Pharma Rivalry: Who Will Emerge as the Drug R&D Empire?

In the current era, driven by both policy and market forces, innovation remains the most prominent keyword in the pharmaceutical industry. Drug R&D is the lifeblood of pharmaceutical companies and the cornerstone that enables them to stand firm in the marketplace. As pharmaceutical companies rush to invest in R&D and innovation, who are the trailblazers of this industry? And who will lead the way in the future? Seizing this opportunity, Yaozhi.com has launched a vote for the “Top 100 Companies with the Strongest Pharmaceutical R&D Capabilities in 2016,” based on data statistics including new drug applications, review and approval processes, and R&D investment.

This voting event is the second national large-scale online activity hosted by Yaozhi.com, titled“Second Edition—Vote for Your Ideal Pharmaceutical R&D Empire”Participating companies that secure rankings through public voting will receive corresponding “Brand Impact Scores,” which will be included in the overall evaluation score for final ranking. Registration for the event is now open and willJune 1–11Voting channel now open.

[Voting Period]

12:00 on June 1, 2017 – 12:00 on June 11, 2017

[Voting Method]

Scan the QR code below via WeChat to access the voting event interface;

[Event Value]

1. This is the second edition of the event, which will continue to be promoted by Yaozhi.com in collaboration with multiple authoritative institutions, mainstream media, pharmaceutical industry media, and relevant pharmaceutical companies. It features an exceptionally long duration, strong industry influence, and a wide reach.

2. This event will far surpass the inaugural edition, with an expected participation of over 600 pharmaceutical companies and more than 3 million individuals, achieving over 4 million impressions;

3. More than 100 mass media outlets and over 30 industry media participated in this event, with viral dissemination enhancing the depth and breadth of coverage, resulting in unprecedented effectiveness and influence;

4. All participants in this event are professionals from the pharmaceutical and healthcare industry, ensuring a highly targeted audience and significant communication value;

5. Participation by industry-leading enterprises, authoritative media, and reputable institutions ensures the high value of the R&D rankings, thereby establishing industry-wide recognition of pharmaceutical companies’ R&D standing;

6. Following the release of the rankings, we will continue to organize the second edition of the offline “2017 World Intelligent Technology Conference – Pharmaceutical Sub-forum,” leveraging its extended dissemination period and high social attention to achieve widespread brand exposure.

7. The voting results of this event will determine the “Brand Ranking” for R&D Strength, which will be unveiled alongside the “Overall Ranking,” “Chemical Drug Ranking,” “Traditional Chinese Medicine Ranking,” and “Biological Drug Ranking” for R&D Strength at the Pharmaceutical Sub-forum of the 2017 World Intelligent Technology Conference. Authoritative institutions will present awards to pharmaceutical companies on-site, thereby enhancing industry recognition of corporate R&D capabilities.